SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

ArriVent BioPharma Files Form 8-K

ArriVent BioPharma filed a Form 8-K. The filing references Oct. 25.

AVBP

Related stories